David W. Miller

David W. Miller is an accomplished leader in the life sciences industry, currently serving as the CEO and Chair of Genesis Research since December 2021, where David W. oversees HEOR, RWE, and market access operations globally. Miller holds multiple strategic roles including Board Member at ELIQUENT Life Sciences, Venture Partner at Atria Ventures, Advisory Board Member at Almaden Genomics, and Board Observer at Aitia. Additionally, Miller serves as Operating Partner for GHO Capital Partners LLP and has been a Board Member for Envision Pharma Group. With a robust background in market access and HEOR from their tenure as Senior Vice President at Biogen, Miller also contributes advisory services through Miller Pharma. Educationally, Miller possesses a Bachelor of Science in Pharmacy from the University of Iowa and a PhD in Pharmacy Administration, Health Economics, and Policy from the University of Maryland Baltimore.